3638 Start with screening Because patients being considered for GLP-1 receptor agonist therapy are already at risk of developing acute pancreatitis due to having type 2 diabetes, obesity or both, screening for other potential risk factors before starting treatment is recommended
Quality and tolerability assessment Colonoscopy was conducted by experienced gastrointestinal endoscopists blinded to the study grouping
Relevant word searches were performed in the PubMed, Embase, Web of Science, Scopus, MEDLINE, and Cochrane Library databases
Bain MA, Milne RW, Evans AM (2006) Disposition and metabolite kinetics of oral L-carnitine in humans
However, pilots with higher BMIs due to muscle mass may still meet FAA medical requirements